Abstract
This review highlights the issue of radiation-induced skin reactions (RISR), emphasizes the high frequency of RISR in patients with cutaneous lymphomas undergoing radiation therapy, and analyzes numerous pathological processes that occur in the skin as a result of ionizing radiation exposure. The review systematically examines external and internal factors influencing the development of RISR, compares diagnostic methods, discusses preventive measures and treatments for radiation dermatitis, and describes the mechanisms of action for drugs used in RISR prophylaxis and treatment. RISR remains a significant problem in radiation therapy, characterized by a high frequency, a wide range of clinical manifestations, and an impact on patients quality of life. The mechanisms, diagnosis, prevention, and treatment of RISR are considered.
Reference45 articles.
1. O'Malley JT, de Masson A, Lowry EL, et al. Radiotherapy eradicates malignant T cells and is associated with improved survival in early-stage mycosis fungoides. Clin Cancer Res. 2020;26(2):408-18.
2. Wei J, Meng L, Hou X, et al. Radiation-induced skin reactions: mechanism and treatment. Cancer Manag Res. 2019;11:167-77.
3. Chan RJ, Blades R, Jones L, et al. A single-blind, randomised controlled trial of StrataXRT® – A silicone-based film-forming gel dressing for prophylaxis and management of radiation dermatitis in patients with head and neck cancer. Radiother Oncol. 2019;139:72-8.
4. Hoeller U, Tribius S, Kuhlmey A, et al. Increasing the rate of late toxicity by changing the score? A comparison of RTOG/EORTC and LENT/SOMA scores. Int J Radiation Oncol Biol Physics. 2003;55(4):1013-18.
5. Cancer Institute N. Common terminology criteria for adverse events (CTCAE) common terminology criteria for adverse events (CTCAE) v5. 0. 2017. Available at: https://ctep.cancer.gov/protocoldevelopment/electronic_applications/docs/ctcae_v5_quick_reference_5x7.pdf. Accessed: 01.06.2023.